Table 2 Prognostic value of ΔALC in different subgroups
Factors | Median OS (months) | Median PFS (months) | |||||
|---|---|---|---|---|---|---|---|
Group A | Group B | p value | Group A | Group B | p value | ||
Combined chemotherapy | Yes | 17.9 | 20 | 0.24 | 10.1 | 12.7 | 0.08 |
No | 9.7 | 14.0 | 0.0017 | 7.9 | 9.3 | 0.052 | |
Tumor length | ≤ 5 cm | 21.1 | 42.2 | 0.063 | 10.0 | 17.4 | 0.144 |
> 5 cm | 12.8 | 14.4 | 0.23 | 8.4 | 11.1 | 0.095 | |
Tumor location | Cervical + Upper thoracic | 21.1 | 37.1 | 0.383 | 10.0 | 13.3 | 0.431 |
Middle + Lower thoracic | 12.2 | 18.4 | 0.007 | 7.8 | 11.4 | 0.006 | |
T stage | < 3 | 18.5 | 46.6 | 0.167 | 10.7 | 42.2 | 0.140 |
≥ 3 | 12.5 | 14.4 | 0.113 | 7.9 | 10.17 | 0.133 | |
N stage | < 2 | 19.0 | 42.2 | 0.230 | 10.7 | 31.9 | 0.683 |
≥ 2 | 12.5 | 16.1 | 0.079 | 7.8 | 12.1 | 0.012 | |
TNM stage | II-III | 12.5 | 42.2 | 0.004 | 10.0 | 16.5 | 0.026 |
IVa | 18.7 | 14.0 | 0.466 | 7.5 | 10.0 | 0.560 | |
minALC* | G1-3 | 15.5 | 27.8 | 0.014 | 8.4 | 13.0 | 0.014 |
G4 | 10 | 14.4 | 0.012 | 8.4 | 7.8 | 0.62 | |